Semaglutide

Semaglutide is a class of medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly used to manage type 2 diabetes and increasingly recognized for their effectiveness in promoting weight loss. These drugs mimic the actions of natural hormones in the body, regulating blood sugar levels and curbing appetite.

Get started

Important safety information

Important Safety Information

COMPOUNDED SEMAGLUTIDE is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

27 kg/m² or greater (overweight or obesity)

Limitations of Use:

Co-administration with other COMPOUNDED SEMAGLUTIDE-containing products or any GLP-1 receptor agonist is not recommended.
The safety and efficacy of coadministration with other products for weight management have not been established.
COMPOUNDED SEMAGLUTIDE has not been studied in patients with a history of pancreatitis.

WARNING: RISK OF THYROID C-CELL TUMORS

In rodents, semaglutide causes thyroid C-cell tumors in clinically relevant exposures. It is unknown whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.
Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors.

Do not take COMPOUNDED SEMAGLUTIDE if you:

Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Have been diagnosed with pancreatitis or have a history of pancreatitis.
Are allergic to semaglutide or any other GLP-1 drug or any of its inactive ingredients.
Have a history of suicidal attempts or active suicidal ideation.

WARNINGS AND PRECAUTIONS:

Acute Pancreatitis: Has occurred in clinical trials. Discontinue promptly if pancreatitis is suspected. Do not restart if pancreatitis is confirmed.
Acute Gallbladder Disease: Gallbladder issues have been observed in clinical trials. Clinical follow-up is needed if cholelithiasis is suspected.
Hypoglycemia: The use of insulin secretagogues or insulin may increase the risk of hypoglycemia, including severe cases. Adjust the dose of insulin secretagogues or insulin accordingly.
Acute Kidney Injury: Monitor renal function when starting or escalating doses in patients reporting severe gastrointestinal side effects.
Hypersensitivity Reactions: Anaphylaxis and angioedema have been reported post-marketing. Discontinue if suspected.
Pregnancy: Semaglutide may cause fetal harm. Discontinue immediately upon pregnancy recognition.
Diabetic Retinopathy Complications: Monitor patients with a history of diabetic retinopathy.
Heart Rate Increase: Monitor heart rate periodically.
Suicidal Behavior and Ideation: Monitor for signs of depression or suicidal thoughts. Discontinue if these symptoms develop.

Side Effects: Most common side effects (incidence ≥ 5%) include:

Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Fatigue
Dyspepsia (indigestion)
Dizziness
Abdominal distension
GERD (gastroesophageal reflux disease)
Headache

Drug Interactions: COMPOUNDED SEMAGLUTIDE delays gastric emptying, which may impact the absorption of oral medications. Use with caution.

Lowers A1C Levels
Helps you feel full faster, longer
Improves the way your body responds to sugars
Semaglutide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate*

24/7 Provider & Nursing support
Medications, syringes, alcohol swabs
Weight monitoring via app
Shipping delivered to your door
Optional nutritional counseling

Semaglutide is typically administered as a once-weekly subcutaneous injection, meaning it is injected just under the skin, usually in the abdomen, thigh, or upper arm. It's important to rotate the injection site each week to avoid irritation. Always follow the dosing instructions provided by your healthcare provider, starting with a lower dose and gradually increasing based on your body's response. Be sure to use a clean needle for each injection and dispose of it safely. If you miss a dose, take it as soon as you remember, unless it's less than 48 hours before your next scheduled dose. Never double up on doses. For optimal results, use semaglutide in combination with a healthy diet and regular exercise

Common side effects of semaglutide may include nausea, vomiting, diarrhea, constipation, and abdominal pain, especially when starting treatment. Other possible side effects include fatigue, dizziness, and decreased appetite. In rare cases, semaglutide can cause more serious side effects like pancreatitis, gallbladder issues, or allergic reactions. If you experience severe abdominal pain, difficulty breathing, or swelling of the face or throat, seek medical attention immediately. Always consult your healthcare provider about any side effects or concerns you may have.

* Only available if prescribed after an online consultation with a healthcare provider.
* This page has been medically reviewed
* Actual price to customer will depend on product and subscription plan purchase.